Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)

Status unconfirmed

Conditions studied: Charcot-Marie-Tooth Disease

In brief

The purpose of this study is to develop and validate a clinical outcome measure to evaluate disability and disease progression of children 3 years of age and younger (infants and toddlers) with various types of Charcot-Marie-Tooth disease (CMT).

Key facts

Study ID

NCT02979145

Run by

Sydney Children's Hospitals Network

People needed

200

Starts

2016-10-01

Last updated by the study team

2016-12-01

Who can join

Age: any, up to 4. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Iowa Health Care — Iowa City, Iowa, United States (enrolling)
• The Children's Hospital at Westmead — Sydney, New South Wales, Australia (enrolling)
• C. Besta Neurological Institute — Milan, Italy (enrolling)
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.